Related Experiment Videos
Nephrotic syndrome in children-a clinical study
Summary
This study analyzed 54 children with Nephrotic Syndrome, finding it more common in males and peaking at age 3. Early-stage cases without nephritic features responded best to Prednisolone therapy.
Area of Science:
- Pediatrics
- Nephrology
- Clinical Biochemistry
Background:
- Nephrotic Syndrome is a significant kidney disorder in children.
- Understanding its clinical and biochemical profile is crucial for effective management.
- Steroid therapy, particularly Prednisolone, is a cornerstone treatment.
Purpose of the Study:
- To describe the clinical and biochemical characteristics of childhood Nephrotic Syndrome.
- To evaluate the response to Prednisolone therapy in affected children.
- To identify factors influencing treatment outcomes.
Main Methods:
- Retrospective analysis of 54 pediatric patients diagnosed with Nephrotic Syndrome over six years.
- Detailed recording of clinical presentations and biochemical markers.
- Assessment of treatment response in 43 patients receiving Prednisolone.
Main Results:
- Nephrotic Syndrome demonstrated higher prevalence in male children.
- The peak incidence occurred around the age of 3 years.
- Patients with recent disease onset and without nephritic features showed an excellent response to Prednisolone.
Conclusions:
- Prednisolone is an effective treatment for Nephrotic Syndrome, especially in early, uncomplicated cases.
- Early diagnosis and intervention in pediatric Nephrotic Syndrome are critical.
- Further research into specific biomarkers could refine treatment strategies.